Rashid Iqbal, MD
Gastroenterology · Fairfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 1 carrier
- Offices
- 13
Offices
13 locations · Sutter Bay Medical Foundation · Sutter Valley Medical Foundation
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · Contra Costa Regional Medical Center · Sutter Delta Medical Center · Sutter Medical Center, Sacramento · Sutter Solano Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Iqbal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A43154 · Current
Licensed to practise in California · since 1986 · expires 2028-09-30 · University of Karachi, Dow Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Sutter Fairfield Surgery Center, LLCAmbulatory Surgery Center · Fairfield, CA3% owner since 2009 · accredited by AAAHCAccreditation Renewed4 inspections, 2 with deficiencies · last 2026-03-31
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Contra Costa Regional Medical CenterMartinez, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Contra Costa Health ServicesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
- Sutter Delta Medical CenterAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Contra Costa Regional Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 188 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 321 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,198 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (0.67 to 5.72) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.36 (1.01 to 19.71) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.08) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.58) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0 to 2.03) · 981 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.948 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.027 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (8.8 to 17.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 35 cases | None | Jul 2023 – Jun 2025 |
What patients said (521 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sutter Delta Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 561 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.47 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 176.46 (114.75 to 238.17) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,274 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,285 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,374 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.4) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,713 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.962 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 116 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.3 · 269 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.1) · 529 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (610 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Solano Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.6 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.36 (106.6 to 218.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,268 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.7 (0.38 to 5.03) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.74 to 11.8) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.48) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 171 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.8 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 162 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.4) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.6 to 18.9) · 322 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (355 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$63,052
Medicare paid this office $63,052 for 265 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 93 | $13,630 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $9,488 | $182 |
| Short return visit (20+ min) | 69 | $6,912 | $67 |
| Diagnostic exam of large bowel using a flexible endoscope | 41 | $5,550 | $135 |
| Biopsy of large bowel using a flexible endoscope | 27 | $4,246 | $152 |
See all 10 services
| Return visit (30+ min) | 93 | $13,630 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $9,488 | $182 |
| Short return visit (20+ min) | 69 | $6,912 | $67 |
| Diagnostic exam of large bowel using a flexible endoscope | 41 | $5,550 | $135 |
| Biopsy of large bowel using a flexible endoscope | 27 | $4,246 | $152 |
| New patient visit (45+ min) | 33 | $4,089 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,677 | $136 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,225 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $2,918 | $195 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,737 | $79 |
Procedures Medicare counted
| Colonoscopy | 175 | More than 91% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 176 | More than 88% of doctors who do this |
Who their Medicare patients are
265 Original Medicare patients in 2024. Average age 72 · Under 65 10% · 85 and older 5% · Women 58% · Also on Medicaid 57% · Health risk score 1.26. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 39% · Chronic kidney disease 23% · Coronary heart disease 20% · COPD 19% · Depression 18% · Heart failure 13% · Atrial fibrillation 12% · Cancer 11% · Stroke 9% · Dementia 5%.
The office billed $228,966, Medicare allowed $87,439 and paid $63,052; for 583 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 265 | 583 | 72 | 1.26 | $228,966 | $63,052 |
| 2023 | 291 | 547 | 71 | 1.15 | $223,516 | $61,535 |
| 2022 | 285 | 491 | 71 | 1.22 | $203,055 | $48,056 |
| 2021 | 301 | 556 | 71 | 1.15 | $227,019 | $58,535 |
| 2020 | 373 | 773 | 70 | 1.36 | $264,085 | $72,044 |
| 2019 | 560 | 1,253 | 70 | 1.44 | $446,140 | $125,823 |
| 2018 | 662 | 1,306 | 69 | 1.36 | $473,252 | $124,202 |
| 2017 | 667 | 1,385 | 70 | 1.36 | $474,526 | $119,324 |
| 2016 | 650 | 1,361 | 69 | 1.27 | $477,850 | $145,101 |
| 2015 | 704 | 1,436 | 70 | 1.24 | $499,702 | $160,773 |
| 2014 | 552 | 1,115 | 70 | 1.05 | $352,674 | $126,696 |
| 2013 | 527 | 984 | 70 | 1.19 | $358,319 | $121,021 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | $11,348 | $192 |
| Return visit (30+ min) | 71 | $11,244 | $98 |
| Biopsy of large bowel using a flexible endoscope | 45 | $6,500 | $141 |
| Short return visit (20+ min) | 66 | $5,502 | $69 |
| Diagnostic exam of large bowel using a flexible endoscope | 43 | $5,370 | $125 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $4,959 | $90 |
| New patient visit (45+ min) | 34 | $4,354 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,179 | $132 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $3,101 | $194 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,556 | $86 |
| Short return visit | 18 | $816 | $35 |
2022: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 64 | $11,834 | $185 |
| Biopsy of large bowel using a flexible endoscope | 42 | $6,181 | $147 |
| Diagnostic exam of large bowel using a flexible endoscope | 44 | $5,814 | $132 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $3,823 | $85 |
| Short return visit (20+ min) | 62 | $3,774 | $53 |
| Return visit (30+ min) | 32 | $3,517 | $88 |
| New patient visit (30+ min) | 62 | $2,969 | $48 |
| Short return visit | 43 | $1,965 | $38 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,565 | $104 |
2021: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 70 | $14,956 | $211 |
| Biopsy of large bowel using a flexible endoscope | 51 | $8,215 | $155 |
| Diagnostic exam of large bowel using a flexible endoscope | 43 | $6,250 | $145 |
| Short return visit (20+ min) | 83 | $5,534 | $49 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $4,845 | $90 |
| New patient visit (30+ min) | 53 | $3,445 | $65 |
| Return visit (30+ min) | 23 | $3,236 | $104 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $2,997 | $200 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,721 | $156 |
| Short return visit | 39 | $1,680 | $35 |
| New patient visit (45+ min) | 14 | $1,643 | $117 |
| New patient visit (15+ min) | 16 | $545 | $34 |
2020: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $11,852 | $204 |
| Short return visit (20+ min) | 130 | $7,735 | $44 |
| Diagnostic exam of large bowel using a flexible endoscope | 50 | $7,619 | $149 |
| Biopsy of large bowel using a flexible endoscope | 36 | $6,188 | $167 |
| New patient visit (30+ min) | 88 | $5,872 | $67 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $5,749 | $198 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 61 | $5,627 | $88 |
| Short return visit | 77 | $2,704 | $29 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,332 | $83 |
| New patient visit (45+ min) | 16 | $2,154 | $135 |
| New patient visit (15+ min) | 43 | $1,731 | $40 |
| Return visit (30+ min) | 15 | $1,477 | $92 |
| New patient visit (10+ min) | 11 | $363 | $33 |
2019: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 101 | $20,639 | $202 |
| Short return visit (20+ min) | 187 | $17,952 | $62 |
| New patient visit (30+ min) | 186 | $14,744 | $79 |
| Biopsy of large bowel using a flexible endoscope | 89 | $13,441 | $151 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 51 | $10,390 | $204 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 100 | $8,867 | $88 |
| Diagnostic exam of large bowel using a flexible endoscope | 58 | $8,442 | $146 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 30 | $6,117 | $204 |
| New patient visit (15+ min) | 110 | $5,597 | $51 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $4,416 | $92 |
| Short return visit | 55 | $2,540 | $35 |
| New patient visit (10+ min) | 20 | $629 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $209 | $19 |
2018: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 115 | $23,304 | $199 |
| Biopsy of large bowel using a flexible endoscope | 85 | $13,109 | $154 |
| Diagnostic exam of large bowel using a flexible endoscope | 90 | $12,064 | $134 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 62 | $11,839 | $191 |
| New patient visit (30+ min) | 149 | $11,369 | $76 |
| New patient visit (15+ min) | 201 | $9,486 | $47 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 88 | $8,001 | $87 |
| Short return visit (20+ min) | 118 | $7,388 | $56 |
| Short return visit | 142 | $5,800 | $31 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $4,246 | $73 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 11 | $1,281 | $116 |
| New patient visit (10+ min) | 15 | $469 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $173 | $13 |
2017: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 110 | $23,982 | $212 |
| Biopsy of large bowel using a flexible endoscope | 110 | $14,444 | $131 |
| Diagnostic exam of large bowel using a flexible endoscope | 105 | $14,120 | $134 |
| New patient visit (15+ min) | 212 | $12,402 | $58 |
| Short return visit | 222 | $11,942 | $37 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 118 | $10,663 | $88 |
| Short return visit (20+ min) | 112 | $5,720 | $45 |
| New patient visit (30+ min) | 84 | $4,915 | $59 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $3,882 | $76 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,614 | $201 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,197 | $116 |
| Injection beneath lining of large bowel using a flexible endoscope | 19 | $1,093 | $55 |
| New patient visit (10+ min) | 29 | $988 | $34 |
2016: 10 services
| New patient visit (30+ min) | 306 | $26,606 | $87 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 117 | $26,159 | $220 |
| Short return visit (20+ min) | 220 | $23,794 | $62 |
| Diagnostic exam of large bowel using a flexible endoscope | 110 | $17,853 | $162 |
| Biopsy of large bowel using a flexible endoscope | 93 | $13,077 | $141 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $9,456 | $860 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 92 | $8,985 | $96 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $5,394 | $88 |
| Short return visit | 45 | $1,906 | $34 |
| New patient visit (10+ min) | 29 | $941 | $32 |
2015: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 110 | $29,287 | $255 |
| Diagnostic exam of large bowel using a flexible endoscope | 132 | $22,104 | $165 |
| Return visit (30+ min) | 188 | $21,895 | $80 |
| Biopsy of large bowel using a flexible endoscope | 112 | $19,947 | $175 |
| New patient visit (30+ min) | 234 | $17,924 | $77 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $8,035 | $91 |
| Short return visit (20+ min) | 94 | $6,996 | $65 |
| New patient visit (45+ min) | 49 | $6,485 | $132 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $5,107 | $80 |
| Long return visit (40+ min) | 30 | $3,134 | $104 |
| Short return visit | 60 | $2,873 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,713 | $101 |
| New patient visit (10+ min) | 36 | $1,219 | $34 |
| New patient visit (15+ min) | 24 | $1,018 | $42 |
2014: 14 services
| Return visit (30+ min) | 165 | $22,071 | $83 |
| New patient visit (30+ min) | 243 | $19,181 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 72 | $18,511 | $257 |
| Diagnostic exam of large bowel using a flexible endoscope | 81 | $14,526 | $179 |
| Biopsy of large bowel using a flexible endoscope | 68 | $14,214 | $209 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $6,114 | $102 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,879 | $232 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $4,311 | $88 |
| New patient visit (15+ min) | 69 | $3,533 | $51 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $3,252 | $232 |
| New patient visit (45+ min) | 22 | $2,348 | $107 |
| Short return visit (20+ min) | 32 | $2,205 | $61 |
| Short return visit | 41 | $2,142 | $39 |
| Long return visit (40+ min) | 16 | $1,612 | $101 |
2013: 13 services
| Biopsy of large bowel using a flexible endoscope | 83 | $17,674 | $213 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 67 | $17,320 | $259 |
| Diagnostic exam of large bowel using a flexible endoscope | 77 | $13,529 | $176 |
| New patient visit (30+ min) | 137 | $10,699 | $78 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $9,813 | $892 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 42 | $9,709 | $231 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $7,507 | $109 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $6,302 | $98 |
| Short return visit | 139 | $6,211 | $36 |
| Short return visit (20+ min) | 63 | $3,968 | $54 |
| Return visit (30+ min) | 43 | $3,825 | $87 |
| New patient visit (15+ min) | 62 | $3,579 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,857 | $103 |
Medicaid work
$202,415 in 2024
Medicaid paid $202,415 for 1,065 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DIAGNOSTIC COLONOSCOPY | 197 | $82,741 |
| COLONOSCOPY W/LESION REMOVAL | 71 | $38,441 |
| New patient visit (45+ min) | 215 | $21,011 |
| Upper gastrointestinal endoscopy with biopsy | 68 | $20,570 |
| COLONOSCOPY AND BIOPSY | 42 | $17,664 |
| Return visit (30+ min) | 153 | $6,397 |
| Short return visit (20+ min) | 235 | $5,666 |
| Clinic visit/encounter, all-inclusive | 15 | $5,496 |
| Service | 54 | $4,430 |
| Service | 15 | $0 |
| 2024 | 1,065 | 10 | 34 | $202,415 |
| 2023 | 1,433 | 10 | 39 | $270,214 |
| 2022 | 527 | 8 | 32 | $132,786 |
| 2021 | 459 | 7 | 33 | $87,791 |
| 2020 | 691 | 10 | 37 | $89,299 |
| 2019 | 1,373 | 9 | 36 | $239,393 |
| 2018 | 1,501 | 8 | 63 | $252,521 |
See the largest Medicaid services in earlier years
2023
| DIAGNOSTIC COLONOSCOPY | 180 | $72,646 |
| Clinic visit/encounter, all-inclusive | 146 | $50,573 |
| COLONOSCOPY W/LESION REMOVAL | 80 | $40,367 |
| COLONOSCOPY AND BIOPSY | 84 | $36,092 |
| Upper gastrointestinal endoscopy with biopsy | 117 | $33,874 |
| Service | 177 | $14,521 |
| New patient visit (45+ min) | 147 | $13,491 |
| Return visit (30+ min) | 154 | $6,789 |
| Short return visit (20+ min) | 217 | $1,860 |
| Service | 131 | $0 |
2022
| DIAGNOSTIC COLONOSCOPY | 124 | $49,638 |
| COLONOSCOPY AND BIOPSY | 60 | $27,121 |
| Upper gastrointestinal endoscopy with biopsy | 78 | $24,198 |
| COLONOSCOPY W/LESION REMOVAL | 34 | $16,278 |
| New patient visit (30+ min) | 166 | $13,136 |
| Return visit (30+ min) | 39 | $1,744 |
| Short return visit (20+ min) | 14 | $446 |
| Short return visit | 12 | $224 |
2021
| Upper gastrointestinal endoscopy with biopsy | 89 | $25,101 |
| COLONOSCOPY AND BIOPSY | 49 | $21,027 |
| COLONOSCOPY W/LESION REMOVAL | 29 | $12,436 |
| DIAGNOSTIC COLONOSCOPY | 29 | $11,064 |
| New patient visit (30+ min) | 139 | $10,721 |
| Clinic visit/encounter, all-inclusive | 12 | $3,991 |
| Short return visit (20+ min) | 112 | $3,451 |
2020
| Upper gastrointestinal endoscopy with biopsy | 119 | $35,430 |
| DIAGNOSTIC COLONOSCOPY | 50 | $19,119 |
| New patient visit (30+ min) | 171 | $12,683 |
| COLONOSCOPY W/LESION REMOVAL | 12 | $5,911 |
| Short return visit (20+ min) | 203 | $5,860 |
| COLONOSCOPY AND BIOPSY | 14 | $5,297 |
| New patient visit (45+ min) | 27 | $2,350 |
| Short return visit | 70 | $1,487 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $638 |
| Return visit (30+ min) | 13 | $523 |
2019
| DIAGNOSTIC COLONOSCOPY | 146 | $60,409 |
| Upper gastrointestinal endoscopy with biopsy | 173 | $47,459 |
| COLONOSCOPY AND BIOPSY | 114 | $45,168 |
| COLONOSCOPY W/LESION REMOVAL | 94 | $44,402 |
| New patient visit (30+ min) | 362 | $25,570 |
| Short return visit (20+ min) | 309 | $7,867 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 102 | $4,558 |
| Diagnostic upper gastrointestinal endoscopy | 13 | $2,571 |
| Short return visit | 60 | $1,391 |
2018
| DIAGNOSTIC COLONOSCOPY | 234 | $90,870 |
| COLONOSCOPY W/LESION REMOVAL | 96 | $41,189 |
| Upper gastrointestinal endoscopy with biopsy | 141 | $41,188 |
| COLONOSCOPY AND BIOPSY | 96 | $35,520 |
| New patient visit (30+ min) | 300 | $20,606 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 330 | $15,557 |
| Short return visit | 189 | $4,348 |
| Short return visit (20+ min) | 115 | $3,244 |
Drugs they prescribed that Part D paid
$444,939
Pharmacies billed $444,939 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 460) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
330 generic and 130 brand-name prescriptions · $444,939 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rinvoq | 20 | $188,517 | $9,426 |
| Linzess | 14 | $12,895 | $921 |
| Sod Sulf-Potass Sulf-Mag Sulf | 107 | $6,731 | $63 |
| Cholestyramine | 11 | $832 | $76 |
| Omeprazole | 67 | $590 | $9 |
See all 11 drugs
| Rinvoq | 20 | $188,517 | $9,426 |
| Linzess | 14 | $12,895 | $921 |
| Sod Sulf-Potass Sulf-Mag Sulf | 107 | $6,731 | $63 |
| Cholestyramine | 11 | $832 | $76 |
| Omeprazole | 67 | $590 | $9 |
| Dicyclomine | 22 | $539 | $25 |
| Gavilyte-G | 36 | $471 | $13 |
| Peg-3350 and Electrolytes | 33 | $465 | $14 |
| Pantoprazole | 27 | $369 | $14 |
| Amitriptyline | 13 | $215 | $17 |
| Loperamide | 15 | $104 | $7 |
Year by year
| 2024 | 460 | 232 | 0% (0) | 28% | $444,939 |
| 2023 | 494 | 274 | 0% (0) | None | $385,816 |
| 2022 | 495 | 253 | 0% (0) | 45% | $137,804 |
| 2021 | 582 | 269 | 0% (0) | 41% | $140,716 |
| 2020 | 609 | 242 | 0% (0) | 38% | $160,296 |
| 2019 | 687 | 308 | 0% (0) | 23% | $239,707 |
| 2018 | 714 | 339 | 0% (0) | 22% | $171,064 |
| 2017 | 849 | 335 | None | 37% | $166,996 |
| 2016 | 888 | 340 | 0% (0) | 44% | $337,291 |
| 2015 | 875 | 316 | 0% (0) | 37% | $491,590 |
| 2014 | 1,047 | 392 | 3% (33) | None | $472,738 |
| 2013 | 1,129 | 396 | 1% (15) | None | $92,201 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Sod Sulf-Potass Sulf-Mag Sulf | 124 | $9,456 | $76 |
| Linzess | 11 | $8,387 | $762 |
| Mesalamine | 14 | $5,869 | $419 |
| Mesalamine Er | 12 | $4,082 | $340 |
| Suprep | 17 | $1,747 | $103 |
| Omeprazole | 70 | $1,455 | $21 |
| Entecavir | 14 | $873 | $62 |
| Gavilyte-G | 43 | $764 | $18 |
| Nortriptyline | 14 | $355 | $25 |
| Pantoprazole | 20 | $312 | $16 |
| Loperamide | 14 | $257 | $18 |
| Peg-3350 and Electrolytes | 11 | $185 | $17 |
2022: 9 drugs
| Cimzia | 12 | $59,733 | $4,978 |
| Suprep | 162 | $18,494 | $114 |
| Mesalamine | 22 | $13,908 | $632 |
| Sod Sulf-Potass Sulf-Mag Sulf | 24 | $1,985 | $83 |
| Omeprazole | 86 | $1,373 | $16 |
| Entecavir | 13 | $767 | $59 |
| Loperamide | 20 | $438 | $22 |
| Pantoprazole | 25 | $368 | $15 |
| Lactulose | 16 | $174 | $11 |
2021: 8 drugs
| Cimzia | 12 | $62,428 | $5,202 |
| Suprep | 166 | $18,546 | $112 |
| Mesalamine | 29 | $16,586 | $572 |
| Dexilant | 20 | $14,948 | $747 |
| Omeprazole | 104 | $1,530 | $15 |
| Pantoprazole | 39 | $688 | $18 |
| Peg 3350-Electrolyte | 21 | $315 | $15 |
| Loperamide | 12 | $230 | $19 |
2020: 13 drugs
| Cimzia | 12 | $54,008 | $4,501 |
| Dexilant | 24 | $18,383 | $766 |
| Mesalamine | 46 | $17,424 | $379 |
| Linzess | 17 | $10,455 | $615 |
| Suprep | 79 | $8,207 | $104 |
| Mesalamine Dr | 11 | $4,534 | $412 |
| Omeprazole | 142 | $2,127 | $15 |
| Peg 3350-Electrolyte | 57 | $871 | $15 |
| Pantoprazole | 30 | $744 | $25 |
| Sulfasalazine Dr | 14 | $481 | $34 |
| Gavilyte-N | 18 | $230 | $13 |
| Famotidine | 15 | $177 | $12 |
| Loperamide | 11 | $139 | $13 |
2019: 11 drugs
| Dexilant | 27 | $16,293 | $603 |
| Mesalamine | 24 | $11,294 | $471 |
| Suprep | 35 | $3,465 | $99 |
| Peg 3350-Electrolyte | 109 | $1,927 | $18 |
| Omeprazole | 150 | $1,884 | $13 |
| Mercaptopurine | 11 | $1,552 | $141 |
| Gavilyte-N | 78 | $1,158 | $15 |
| Pantoprazole | 56 | $1,057 | $19 |
| Ranitidine | 13 | $286 | $22 |
| Dicyclomine | 22 | $237 | $11 |
| Famotidine | 12 | $123 | $10 |
2018: 12 drugs
| Dexilant | 18 | $9,635 | $535 |
| Apriso | 23 | $8,327 | $362 |
| Suprep | 29 | $2,713 | $94 |
| Peg 3350-Electrolyte | 125 | $2,125 | $17 |
| Omeprazole | 141 | $1,506 | $11 |
| Gavilyte-N | 74 | $1,198 | $16 |
| Esomeprazole Magnesium | 19 | $1,148 | $60 |
| Pantoprazole | 58 | $610 | $11 |
| Polyethylene Glycol 3350 | 20 | $486 | $24 |
| Azathioprine | 16 | $184 | $12 |
| Dicyclomine | 30 | $175 | $6 |
| Famotidine | 17 | $162 | $10 |
2017: 22 drugs
| Lialda | 33 | $35,233 | $1,068 |
| Apriso | 22 | $9,785 | $445 |
| Nexium | 21 | $9,722 | $463 |
| Linzess | 18 | $6,826 | $379 |
| Suprep | 75 | $6,526 | $87 |
| Balsalazide Disodium | 19 | $2,357 | $124 |
| Peg 3350-Electrolyte | 90 | $1,321 | $15 |
| Mercaptopurine | 18 | $1,277 | $71 |
| Esomeprazole Magnesium | 17 | $1,257 | $74 |
| Gavilyte-N | 78 | $1,230 | $16 |
| Omeprazole | 152 | $1,138 | $7 |
| Pantoprazole | 38 | $485 | $13 |
| Polyethylene Glycol 3350 | 30 | $414 | $14 |
| Rabeprazole | 13 | $339 | $26 |
| Ranitidine | 19 | $252 | $13 |
| Dicyclomine | 23 | $187 | $8 |
| Sucralfate | 11 | $165 | $15 |
| Azathioprine | 11 | $146 | $13 |
| Lactulose | 11 | $123 | $11 |
| Famotidine | 14 | $89 | $6 |
| Nortriptyline | 11 | $69 | $6 |
| Spironolactone | 13 | $58 | $4 |
2016: 16 drugs
| Lialda | 45 | $33,786 | $751 |
| Xifaxan | 13 | $23,674 | $1,821 |
| Nexium | 32 | $16,091 | $503 |
| Linzess | 41 | $13,162 | $321 |
| Suprep | 92 | $7,528 | $82 |
| Apriso | 25 | $6,911 | $276 |
| Amitiza | 18 | $6,211 | $345 |
| Dexilant | 18 | $4,724 | $262 |
| Esomeprazole Magnesium | 11 | $4,010 | $365 |
| Polyethylene Glycol 3350 | 56 | $1,255 | $22 |
| Omeprazole | 170 | $1,225 | $7 |
| Gavilyte-N | 70 | $1,187 | $17 |
| Peg 3350-Electrolyte | 76 | $1,139 | $15 |
| Azathioprine | 18 | $469 | $26 |
| Dicyclomine | 30 | $285 | $9 |
| Pantoprazole | 20 | $219 | $11 |
2015: 19 drugs
| Harvoni | 12 | $375,597 | $31,300 |
| Lialda | 21 | $14,305 | $681 |
| Nexium | 26 | $12,203 | $469 |
| Linzess | 34 | $9,996 | $294 |
| Dexilant | 31 | $7,949 | $256 |
| Suprep | 64 | $5,198 | $81 |
| Amitiza | 15 | $4,901 | $327 |
| Apriso | 23 | $4,583 | $199 |
| Mercaptopurine | 15 | $1,577 | $105 |
| Gavilyte-N | 87 | $1,539 | $18 |
| Omeprazole | 159 | $1,510 | $9 |
| Polyethylene Glycol 3350 | 39 | $1,129 | $29 |
| Peg 3350-Electrolyte | 58 | $1,056 | $18 |
| Pantoprazole | 37 | $525 | $14 |
| Dicyclomine | 46 | $413 | $9 |
| Lactulose | 11 | $207 | $19 |
| Spironolactone | 13 | $169 | $13 |
| Ranitidine | 19 | $102 | $5 |
| Famotidine | 12 | $70 | $6 |
2014: 26 drugs
| Sovaldi | 11 | $312,831 | $28,439 |
| Nexium | 43 | $17,596 | $409 |
| Xifaxan | 11 | $15,492 | $1,408 |
| Lialda | 18 | $14,366 | $798 |
| Linzess | 31 | $8,077 | $261 |
| Asacol Hd | 11 | $6,236 | $567 |
| Delzicol | 13 | $4,383 | $337 |
| Apriso | 17 | $3,328 | $196 |
| Omeprazole | 215 | $2,462 | $11 |
| Dexilant | 12 | $2,178 | $181 |
| Peg-3350 | 91 | $1,854 | $20 |
| Mercaptopurine | 18 | $1,765 | $98 |
| Suprep | 17 | $1,321 | $78 |
| Gavilyte-N | 65 | $1,308 | $20 |
| Polyethylene Glycol 3350 | 22 | $815 | $37 |
| Hydrocodone-Acetaminophen | 30 | $757 | $25 |
| Trilyte With Flavor Packets | 36 | $701 | $19 |
| Dicyclomine | 47 | $576 | $12 |
| Peg 3350-Electrolyte | 22 | $261 | $12 |
| Pantoprazole | 24 | $252 | $10 |
| Levothyroxine | 13 | $204 | $16 |
| Spironolactone | 11 | $191 | $17 |
| Carvedilol | 18 | $144 | $8 |
| Simvastatin | 11 | $141 | $13 |
| Ranitidine | 29 | $131 | $5 |
| Ciprofloxacin | 12 | $61 | $5 |
2013: 18 drugs
| Nexium | 37 | $13,948 | $377 |
| Aciphex | 15 | $9,461 | $631 |
| Suprep | 56 | $4,066 | $73 |
| Omeprazole | 266 | $3,030 | $11 |
| Peg-3350 With Flavor Packs | 115 | $2,361 | $21 |
| Mercaptopurine | 15 | $1,906 | $127 |
| Dexilant | 12 | $1,871 | $156 |
| Gavilyte-N | 56 | $1,196 | $21 |
| Nystatin | 21 | $1,041 | $50 |
| Trilyte With Flavor Packets | 46 | $855 | $19 |
| Pantoprazole | 49 | $799 | $16 |
| Polyethylene Glycol 3350 | 18 | $363 | $20 |
| Dicyclomine | 43 | $335 | $8 |
| Simvastatin | 21 | $183 | $9 |
| Carvedilol | 22 | $171 | $8 |
| Famotidine | 19 | $124 | $7 |
| Ranitidine | 21 | $84 | $4 |
| Furosemide | 11 | $48 | $4 |
Money from drug and device companies
$288 in 2025
| 2025 | 4 | 12 | None | $288 |
| 2024 | 4 | 5 | None | $124 |
| 2023 | 5 | 7 | None | $161 |
| 2022 | 2 | 3 | None | $43 |
| 2021 | 1 | 2 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $120 | 4 payments
|
| Pfizer | Xeljanz | $79 | 3 payments
|
| Abbvie | Mavyret | $46 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Eohilia | $43 | 2 payments
|
See all 12 published payments
| Abbvie | Meals · 2025-09-09 | Rinvoq | $15 |
| Abbvie | Meals · 2025-08-13 | Mavyret | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-22 | Eohilia | $25 |
| Janssen Biotech | Meals · 2025-07-08 | Tremfya | $38 |
| Abbvie | Meals · 2025-07-03 | Mavyret | $15 |
| Janssen Biotech | Meals · 2025-06-17 | Tremfya | $35 |
| Pfizer | Meals · 2025-06-10 | Xeljanz | $30 |
| Janssen Biotech | Meals · 2025-05-06 | Tremfya | $27 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-01 | Entyvio | $18 |
| Janssen Biotech | Meals · 2025-03-11 | Tremfya | $20 |
| Pfizer | Meals · 2025-03-04 | Xeljanz | $24 |
| Pfizer | Meals · 2025-01-07 | Xeljanz | $25 |
See earlier years (2024, 2023, 2022, 2021)
2024: $124
| Janssen Biotech | Tremfya | $51 | 2 payments
|
| Pfizer | Velsipity | $30 | 1 payment
|
| CapsoVision | Capsocam Plus | $24 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $19 | 1 payment
|
2023: $161
| Celgene | Zeposia | $42 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $42 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $35 | 1 payment
|
| Janssen Biotech | Remicade | $28 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $14 | 1 payment
|
2022: $43
| Abbvie | Humira | $26 | 2 payments
|
| Boston Scientific | General - Endochoice | $17 | 1 payment
|
2021: $31
| AbbVie | Creon | $31 | 2 payments
|
Professional record
- NPI
- 1942285879
- Licence
- CA A43154California A43154: Current · expires 2028-09-30
- Group
- Sutter Bay Medical Foundation · Sutter Valley Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A431541
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1261 Travis Blvd, Ste 170, Fairfield, CA, 94533
- NPI first listed
- 2005-12-14
- NPI last updated
- 2024-12-31
- NPI record certified
- 2024-12-31
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2450 Ashby Ave, Berkeley, CA, 94705